Immunity & Inflammation

The science behind our bodies' defense lines

Researchers reveal a crucial process in the working of the immune system

Researchers reveal a crucial process in the working of the immune system

VIB researchers show how dendritic cells mature without causing an immune response

May 15, 2023

Decoding the satiety signal

Decoding the satiety signal

Research reveals how leptin and its receptor work together to regulate hunger signals

March 24, 2023

Excess salt cuts energy supply of immune regulators

Excess salt cuts energy supply of immune regulators

Too much salt can disrupt the energy metabolism in regulatory immune cells

February 7, 2023

Scientists discover a new brake on cell death

Scientists discover a new brake on cell death

The protein ATG9A blocks the cell-killing signal of tumor necrosis factor and prevents unwanted cell death

December 19, 2022

Protecting ourselves from herpes: when trash becomes treasure

Protecting ourselves from herpes: when trash becomes treasure

Mutations in a key gene that was thought to be 'junk' DNA are linked to the risk of encephalitis after HSV-1 infection.

November 21, 2022

Refining immunotherapy: a story of different cell types

Refining immunotherapy: a story of different cell types

Training our immune system to recognize and attack tumors – immunotherapy – holds great promise for cancer therapy. New research by scientists from VIB, VUB, UGent, KU Leuven, and international partner Roche now shows why some patients don’t respond to immunotherapy. By clarifying the role of different cell types involved in the immune system’s response, this work by the team of Prof. Damya Laoui is an important step toward personalized treatment for cancer patients and is published in Cancer Research.

August 18, 2022

About VIB

VIB’s core mission is to generate disruptive insights in the molecular underpinning of life and to translate these actively into impactful innovations for patients and society. VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research. As such, they are pushing the boundaries of what we know about molecular mechanisms and how they rule living organisms such as human beings, animals, plants, and microorganisms. Based on a close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University – and supported by a solid funding program, VIB unites the expertise of all its collaborators and research groups in a single institute. VIB’s technology transfer activities translate research results into concrete benefits for society such as new diagnostics and therapies and agricultural innovations. These applications are often developed by young start-ups from VIB or through collaborations with other companies. This also leads to additional employment and bridges the gap between scientific research and entrepreneurship. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information. 

More info can be found on www.vib.be.

Contact